Clover Health Investments, Corp. CLOV delivered a loss per share of 2 cents in the third quarter of 2024, narrower than the ...

UBS has recently initiated Clover Health Investments Corp (CLOV) stock to Neutral rating, as announced on October 7, 2024, according to Finviz. Earlier, on February 2, 2022, Cowen had raised the stock ...

The heavy selling pressure might have exhausted for Clover Health Investments (CLOV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall ...

On Friday, Clover Health Investments Corp (CLOV) stock saw a decline, ending the day at $3.41 which represents a decrease of $-0.26 or -7.08% from the prior close of $3.67. The stock opened at $3.69 ...

Year to date, shares of Clover Health have gained 340.1%. The stock has outperformed the Medical Info Systems’ 17.8% decline. CLOV shares also outperformed the Zacks Medical sector’s increase ...

Clover Health's pivot to profitability over growth has led to significant earnings improvements. See why I rate CLOV stock as ...

Clover Health Investments, Corp. (NASDAQ:CLOV – Get Free Report) saw unusually large options trading on Thursday. Stock investors purchased 62,471 call options on the company. This represents an ...

They set a “neutral” rating and a $4.00 price objective on the stock. CLOV stock opened at $3.41 on Monday. Clover Health Investments has a 12 month low of $0.61 and a 12 month high of $4.71.

A downtrend has been apparent in Clover Health Investments, Corp. (CLOV) lately. While the stock has lost 23.1% over the past week, it could witness a trend reversal as a hammer chart pattern was ...